Ankündigung • Jun 30
Weihai Guangwei Composites Co., Ltd. to Report First Half, 2026 Results on Aug 25, 2026 Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2026 results on Aug 25, 2026 Major Estimate Revision • Apr 30
Consensus EPS estimates fall by 20% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from CN¥3.29b to CN¥3.15b. EPS estimate also fell from CN¥1.19 per share to CN¥0.951 per share. Net income forecast to grow 43% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥38.17. Share price fell 7.8% to CN¥33.00 over the past week. Ankündigung • Apr 24
Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 20, 2026 Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Weihai, Shandong China Price Target Changed • Apr 07
Price target increased by 10% to CN¥37.60 Up from CN¥34.03, the current price target is an average from 3 analysts. New target price is 13% above last closing price of CN¥33.14. Stock is up 21% over the past year. The company is forecast to post earnings per share of CN¥1.09 for next year compared to CN¥0.73 last year. Ankündigung • Mar 31
Weihai Guangwei Composites Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 Reported Earnings • Mar 31
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: CN¥0.73 (down from CN¥0.90 in FY 2024). Revenue: CN¥2.86b (up 17% from FY 2024). Net income: CN¥603.4m (down 19% from FY 2024). Profit margin: 21% (down from 30% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 26%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥34.79, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 3.8% over the past three years. Reported Earnings • Jan 29
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: CN¥0.72 (down from CN¥0.90 in FY 2024). Revenue: CN¥2.86b (up 17% from FY 2024). Net income: CN¥601.4m (down 19% from FY 2024). Profit margin: 21% (down from 30% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 26%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. New Risk • Jan 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (113% cash payout ratio). Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (21% net profit margin). Valuation Update With 7 Day Price Move • Jan 12
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥46.47, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 18% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.26 per share. Ankündigung • Dec 31
Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Buy Or Sell Opportunity • Dec 29
Now 37% overvalued after recent price rise Over the last 90 days, the stock has risen 32% to CN¥40.05. The fair value is estimated to be CN¥29.26, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 52% in 2 years. Earnings are forecast to grow by 113% in the next 2 years. Price Target Changed • Nov 19
Price target decreased by 8.9% to CN¥34.28 Down from CN¥37.60, the current price target is an average from 4 analysts. New target price is 21% above last closing price of CN¥28.40. Stock is down 20% over the past year. The company is forecast to post earnings per share of CN¥0.73 for next year compared to CN¥0.90 last year. New Risk • Oct 28
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (113% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (21% net profit margin). Reported Earnings • Oct 28
Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2025 results: EPS: CN¥0.17 (down from CN¥0.30 in 3Q 2024). Revenue: CN¥785.3m (up 5.2% from 3Q 2024). Net income: CN¥145.4m (down 41% from 3Q 2024). Profit margin: 19% (down from 33% in 3Q 2024). Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) missed analyst estimates by 41%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 15% per year. Ankündigung • Sep 30
Weihai Guangwei Composites Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Weihai Guangwei Composites Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Reported Earnings • Aug 19
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: EPS: CN¥0.14 (down from CN¥0.26 in 2Q 2024). Revenue: CN¥635.5m (down 1.4% from 2Q 2024). Net income: CN¥114.6m (down 46% from 2Q 2024). Profit margin: 18% (down from 33% in 2Q 2024). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 18%. Earnings per share (EPS) also missed analyst estimates by 56%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 12% per year. Ankündigung • Jul 02
Weihai Guangwei Composites Co., Ltd. to Report First Half, 2025 Results on Aug 19, 2025 Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2025 results on Aug 19, 2025 Major Estimate Revision • May 13
Consensus EPS estimates fall by 11%, revenue upgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from CN¥2.65b to CN¥2.86b. EPS estimate fell from CN¥1.19 to CN¥1.06 per share. Net income forecast to grow 27% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target down from CN¥37.60 to CN¥36.40. Share price rose 2.9% to CN¥30.40 over the past week. Price Target Changed • Apr 26
Price target decreased by 7.3% to CN¥37.60 Down from CN¥40.58, the current price target is an average from 5 analysts. New target price is 31% above last closing price of CN¥28.75. Stock is up 9.5% over the past year. The company is forecast to post earnings per share of CN¥1.19 for next year compared to CN¥0.90 last year. Ankündigung • Apr 23
Weihai Guangwei Composites Co., Ltd. Approves Cash Dividend for 2024 Weihai Guangwei Composites Co., Ltd. at its Annual General Meeting held on 21 April 2025 approved cash dividend of CNY 5.00000000 per 10 shares (tax included) for 2024. Major Estimate Revision • Apr 07
Consensus EPS estimates fall by 14% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥3.08b to CN¥3.04b. EPS estimate also fell from CN¥1.30 per share to CN¥1.12 per share. Net income forecast to grow 25% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥40.58 to CN¥38.39. Share price fell 13% to CN¥27.05 over the past week. Ankündigung • Apr 02
Weihai Guangwei Composites Co., Ltd. Announces Profit Distribution Proposal for the Year 2024 Weihai Guangwei Composites Co., Ltd. announced profit distribution proposal final Cash dividend/10 shares (tax included) is CNY 5.00000 for the year 2024. Reported Earnings • Apr 01
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥0.90 (down from CN¥1.05 in FY 2023). Revenue: CN¥2.45b (down 2.7% from FY 2023). Net income: CN¥741.2m (down 15% from FY 2023). Profit margin: 30% (down from 35% in FY 2023). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 10%. Earnings per share (EPS) also missed analyst estimates by 17%. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Ankündigung • Apr 01
Weihai Guangwei Composites Co., Ltd., Annual General Meeting, Apr 21, 2025 Weihai Guangwei Composites Co., Ltd., Annual General Meeting, Apr 21, 2025, at 14:00 China Standard Time. Location: No. 130, Tianjin Road, Gaoqu, Weihai, Shandong China Ankündigung • Mar 31
Weihai Guangwei Composites Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Ankündigung • Dec 31
Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2024 Results on Apr 22, 2025 Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2024 results on Apr 22, 2025 Price Target Changed • Oct 29
Price target increased by 19% to CN¥36.13 Up from CN¥30.30, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of CN¥34.90. Stock is up 36% over the past year. The company is forecast to post earnings per share of CN¥1.06 for next year compared to CN¥1.05 last year. Reported Earnings • Oct 28
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: CN¥0.30 (up from CN¥0.25 in 3Q 2023). Revenue: CN¥746.3m (up 43% from 3Q 2023). Net income: CN¥246.7m (up 19% from 3Q 2023). Profit margin: 33% (down from 40% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 6.8%. Earnings per share (EPS) also missed analyst estimates by 8.3%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Ankündigung • Sep 30
Weihai Guangwei Composites Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024 Weihai Guangwei Composites Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to CN¥32.92, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 16% over the past three years. Reported Earnings • Aug 27
Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2024 results: EPS: CN¥0.26 (down from CN¥0.29 in 2Q 2023). Revenue: CN¥644.5m (down 3.4% from 2Q 2023). Net income: CN¥211.0m (down 13% from 2Q 2023). Profit margin: 33% (down from 36% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue exceeded analyst estimates by 16%. Earnings per share (EPS) missed analyst estimates by 9.5%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Price Target Changed • Jul 10
Price target decreased by 7.1% to CN¥31.70 Down from CN¥34.12, the current price target is an average from 4 analysts. New target price is 22% above last closing price of CN¥25.98. Stock is down 12% over the past year. The company is forecast to post earnings per share of CN¥1.18 for next year compared to CN¥1.05 last year. Ankündigung • Jun 29
Weihai Guangwei Composites Co., Ltd. to Report First Half, 2024 Results on Aug 27, 2024 Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2024 results on Aug 27, 2024 Ankündigung • Jun 26
Weihai Guangwei Composites Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 03 July 2024 Weihai Guangwei Composites Co., Ltd. announced final cash dividend of CNY 5.00 per 10 shares on A shares (tax included) for the year 2023. Record date: 02 July 2024, Ex-date: 03 July 2024 and Payment date: 03 July 2024. Reported Earnings • Apr 09
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥1.05 (down from CN¥1.13 in FY 2022). Revenue: CN¥2.52b (flat on FY 2022). Net income: CN¥873.2m (down 6.5% from FY 2022). Profit margin: 35% (down from 37% in FY 2022). Revenue missed analyst estimates by 5.1%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Ankündigung • Mar 30
Weihai Guangwei Composites Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024 Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024 Price Target Changed • Mar 26
Price target decreased by 8.2% to CN¥32.44 Down from CN¥35.33, the current price target is an average from 5 analysts. New target price is 8.6% above last closing price of CN¥29.87. Stock is down 12% over the past year. The company is forecast to post earnings per share of CN¥1.25 for next year compared to CN¥1.05 last year. Buy Or Sell Opportunity • Mar 22
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 18% to CN¥31.36. The fair value is estimated to be CN¥25.59, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 9.3%. Revenue is forecast to grow by 51% in 2 years. Earnings are forecast to grow by 47% in the next 2 years. Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥27.24, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.65 per share. Major Estimate Revision • Feb 05
Consensus EPS estimates fall by 10% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥3.38b to CN¥3.10b. EPS estimate also fell from CN¥1.43 per share to CN¥1.29 per share. Net income forecast to grow 23% next year vs 59% growth forecast for Chemicals industry in China. Consensus price target of CN¥35.03 unchanged from last update. Share price rose 9.8% to CN¥24.37 over the past week. Reported Earnings • Jan 30
Full year 2023 earnings released: EPS: CN¥1.05 (vs CN¥1.13 in FY 2022) Full year 2023 results: EPS: CN¥1.05 (down from CN¥1.13 in FY 2022). Revenue: CN¥2.52b (flat on FY 2022). Net income: CN¥869.1m (down 7.0% from FY 2022). Profit margin: 35% (down from 37% in FY 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings. Ankündigung • Jan 01
Weihai Guangwei Composites Co., Ltd. (SZSE:300699) announces an Equity Buyback for CNY 300 million worth of its shares. Weihai Guangwei Composites Co., Ltd. (SZSE:300699) announces a share repurchase program. Under the program, the company will repurchase up to CNY 300 million worth of its Class A shares. The shares will be repurchased at no more than CNY 37.35 per share. The purpose of the program is to maintain company value and shareholder rights. The plan will be valid for 3 months. Ankündigung • Dec 30
Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2023 Results on Apr 09, 2024 Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2023 results on Apr 09, 2024 Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥26.53, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥27.12 per share. Reported Earnings • Oct 27
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: EPS: CN¥0.25 (down from CN¥0.29 in 3Q 2022). Revenue: CN¥523.2m (down 16% from 3Q 2022). Net income: CN¥208.0m (down 15% from 3Q 2022). Profit margin: 40% (in line with 3Q 2022). Revenue missed analyst estimates by 29%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Price Target Changed • Aug 16
Price target decreased by 12% to CN¥38.97 Down from CN¥44.06, the current price target is an average from 5 analysts. New target price is 43% above last closing price of CN¥27.20. Stock is down 43% over the past year. The company is forecast to post earnings per share of CN¥1.12 for next year compared to CN¥1.13 last year. Reported Earnings • Aug 15
Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.36 in 2Q 2022). Revenue: CN¥666.9m (down 7.8% from 2Q 2022). Net income: CN¥241.8m (down 19% from 2Q 2022). Profit margin: 36% (down from 41% in 2Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) exceeded analyst estimates by 74%. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. Ankündigung • Jul 01
Weihai Guangwei Composites Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023 Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2023 results on Aug 15, 2023 Price Target Changed • Jun 22
Price target decreased by 9.1% to CN¥46.88 Down from CN¥51.58, the current price target is an average from 6 analysts. New target price is 64% above last closing price of CN¥28.63. Stock is down 18% over the past year. The company is forecast to post earnings per share of CN¥1.34 for next year compared to CN¥1.13 last year. Upcoming Dividend • May 04
Upcoming dividend of CN¥0.70 per share at 1.3% yield Eligible shareholders must have bought the stock before 11 May 2023. Payment date: 11 May 2023. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 1.3%. Lower than top quartile of Chinese dividend payers (1.9%). Lower than average of industry peers (1.9%). Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥51.06, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.6% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥34.88 per share. Reported Earnings • Mar 29
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥1.80 (up from CN¥1.46 in FY 2021). Revenue: CN¥2.51b (down 3.7% from FY 2021). Net income: CN¥934.3m (up 23% from FY 2021). Profit margin: 37% (up from 29% in FY 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 16%. Earnings per share (EPS) also missed analyst estimates by 4.7%. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Price Target Changed • Mar 29
Price target decreased by 11% to CN¥86.46 Down from CN¥97.11, the current price target is an average from 8 analysts. New target price is 67% above last closing price of CN¥51.92. Stock is down 14% over the past year. The company is forecast to post earnings per share of CN¥2.25 for next year compared to CN¥1.80 last year. Reported Earnings • Jan 12
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥1.80 (up from CN¥1.46 in FY 2021). Revenue: CN¥2.52b (down 3.4% from FY 2021). Net income: CN¥931.9m (up 23% from FY 2021). Profit margin: 37% (up from 29% in FY 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 5.2%. Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Oct 25
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Third quarter 2022 results: EPS: CN¥0.47 (up from CN¥0.35 in 3Q 2021). Revenue: CN¥625.8m (down 7.9% from 3Q 2021). Net income: CN¥244.7m (up 33% from 3Q 2021). Profit margin: 39% (up from 27% in 3Q 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 29%. Earnings per share (EPS) also missed analyst estimates by 8.3%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Oct 14
Price target increased to CN¥91.83 Up from CN¥81.88, the current price target is an average from 5 analysts. New target price is 17% above last closing price of CN¥78.80. Stock is up 26% over the past year. The company is forecast to post earnings per share of CN¥1.91 for next year compared to CN¥1.46 last year. Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥86.02, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 111% over the past three years. Reported Earnings • Aug 17
Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.42 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.42 in 2Q 2021). Revenue: CN¥723.6m (up 9.9% from 2Q 2021). Net income: CN¥298.1m (up 38% from 2Q 2021). Profit margin: 41% (up from 33% in 2Q 2021). The increase in margin was primarily driven by higher revenue. Over the next year, revenue is forecast to grow 36%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 18
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥68.39, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 92% over the past three years. Price Target Changed • Jul 15
Price target increased to CN¥83.18 Up from CN¥70.41, the current price target is an average from 8 analysts. New target price is 22% above last closing price of CN¥68.39. Stock is down 2.7% over the past year. The company is forecast to post earnings per share of CN¥1.92 for next year compared to CN¥1.46 last year. Ankündigung • May 24
Weihai Guangwei Composites Co., Ltd. Announces Cash Dividend, Payable on May 27, 2022 Weihai Guangwei Composites Co., Ltd. announced 2021 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 5.00000000. Record date as 26 May 2022, ex-date as May 27, 2022 and payment date as May 27, 2022. Ankündigung • May 20
Weihai Guangwei Composites Co., Ltd. Approves Cash Dividend for 2021 Weihai Guangwei Composites Co., Ltd. its Annual General Meeting of 2021 on 18 May 2022 approved Cash dividend of CNY 5.00000000 per 10 shares (tax included) for 2021. Valuation Update With 7 Day Price Move • May 02
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥49.81, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥22.42 per share. Reported Earnings • Apr 27
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: CN¥0.40 (down from CN¥0.42 in 1Q 2021). Revenue: CN¥590.9m (down 5.5% from 1Q 2021). Net income: CN¥207.5m (down 5.0% from 1Q 2021). Profit margin: 35% (in line with 1Q 2021). Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) also missed analyst estimates by 5.0%. Over the next year, revenue is forecast to grow 36%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Independent Director Wenguang Tian is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Ankündigung • Apr 13
Weihai Guangwei Composites Co., Ltd. Proposes Dividend for 2021 Weihai Guangwei Composites Co., Ltd. proposed Cash dividend/10 shares (tax included) of CNY 5.00000000. Reported Earnings • Apr 12
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: CN¥1.46 (up from CN¥1.24 in FY 2020). Revenue: CN¥2.61b (up 23% from FY 2020). Net income: CN¥758.4m (up 18% from FY 2020). Profit margin: 29% (down from 30% in FY 2020). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) also missed analyst estimates by 5.0%. Over the next year, revenue is forecast to grow 31%, compared to a 49% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.33 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥679.3m (up 14% from 3Q 2020). Net income: CN¥184.2m (up 6.7% from 3Q 2020). Profit margin: 27% (down from 29% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 24
Second quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.35 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥658.4m (up 27% from 2Q 2020). Net income: CN¥215.6m (up 20% from 2Q 2020). Profit margin: 33% (down from 35% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 03
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥79.91, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years. Ankündigung • May 22
Weihai Guangwei Composites Co., Ltd. Announces Final Dividend on Its A Share for the Year of 2020, Payable on 27 May 2021 Weihai Guangwei Composites Co., Ltd. announced final dividend of CNY 5.00000000 per 10 shares (tax included) on its A share for the year 2020. Record date: 26 May 2021, Ex-date: 27 May 2021 and Payment date: 27 May 2021. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.33 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥625.0m (up 28% from 1Q 2020). Net income: CN¥218.5m (up 27% from 1Q 2020). Profit margin: 35% (in line with 1Q 2020). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 30
Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.01 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.12b (up 23% from FY 2019). Net income: CN¥641.7m (up 23% from FY 2019). Profit margin: 30% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Mar 04
New 90-day low: CN¥71.80 The company is down 9.0% from its price of CN¥79.25 on 04 December 2020. The Chinese market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥12.18 per share. Ankündigung • Feb 24
Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021 Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2020 results on Mar 30, 2021 Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥74.59, the stock is trading at a trailing P/E ratio of 60.2x, down from the previous P/E ratio of 73x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past three years are 133%. Reported Earnings • Feb 02
Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.01 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.12b (up 23% from FY 2019). Net income: CN¥641.6m (up 23% from FY 2019). Profit margin: 30% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth. Analyst Estimate Surprise Post Earnings • Feb 02
Revenue beats expectations Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Over the next year, revenue is forecast to grow 24%, compared to a 51% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Dec 25
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥89.09, the stock is trading at a trailing P/E ratio of 76.8x, up from the previous P/E ratio of 66.7x. This compares to an average P/E of 34x in the Chemicals industry in China. Total returns to shareholders over the past three years are 95%.